Your browser doesn't support javascript.
loading
Tumor edge-to-core transition promotes malignancy in primary-to-recurrent glioblastoma progression in a PLAGL1/CD109-mediated mechanism.
Li, Chaoxi; Cho, Hee Jin; Yamashita, Daisuke; Abdelrashid, Moaaz; Chen, Qin; Bastola, Soniya; Chagoya, Gustavo; Elsayed, Galal A; Komarova, Svetlana; Ozaki, Saya; Ohtsuka, Yoshihiro; Kunieda, Takeharu; Kornblum, Harley I; Kondo, Toru; Nam, Do-Hyun; Nakano, Ichiro.
Afiliação
  • Li C; Department of Neurosurgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Cho HJ; Research Institute for Future Medicine, Samsung Medical Center, Seoul, Republic of Korea.
  • Yamashita D; Institute for Refractory Cancer Research, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Abdelrashid M; Department of Neurosurgery, Ehime University, Japan.
  • Chen Q; Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Bastola S; Department of Geriatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Chagoya G; Intellectual and Developmental Disabilities Research Center, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
  • Elsayed GA; Department of Neurosurgery, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Komarova S; Department of Neurosurgery, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Ozaki S; Department of Neurosurgery, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Ohtsuka Y; Department of Neurosurgery, Ehime University, Japan.
  • Kunieda T; Department of Neurosurgery, Ehime University, Japan.
  • Kornblum HI; Department of Neurosurgery, Ehime University, Japan.
  • Kondo T; Intellectual and Developmental Disabilities Research Center, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
  • Nam DH; Division of Stem Cell Biology, Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan.
  • Nakano I; Research Institute for Future Medicine, Samsung Medical Center, Seoul, Republic of Korea.
Neurooncol Adv ; 2(1): vdaa163, 2020.
Article em En | MEDLINE | ID: mdl-33392508
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Neurooncol Adv Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Neurooncol Adv Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China